Cargando…

Decreased serum interleukin‐41/Metrnl levels in patients with Graves' disease

BACKGROUND: Interleukin (IL)‐41, also known as Metrnl, is a novel immunomodulatory cytokine, which is involved in the pathogenesis of many inflammatory and metabolic diseases, but its role in thyroid autoimmune diseases is not clear. The aim of this study was to evaluate the serum IL‐41 levels in pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Luping, Huang, Guoqing, Weng, Linjie, Xu, Jialu, Li, Yan, Cui, Wugeng, Li, Mingcai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550969/ https://www.ncbi.nlm.nih.gov/pubmed/36036749 http://dx.doi.org/10.1002/jcla.24676

Ejemplares similares

Low serum interleukin‐38 levels in patients with Graves’ disease and Hashimoto’s thyroiditis
por: Xu, Jialu, et al.
Publicado: (2021)

Low levels of serum IL‐39 are associated with autoimmune thyroid disease
por: Weng, Linjie, et al.
Publicado: (2022)

Endothelial METRNL determines circulating METRNL level and maintains endothelial function against atherosclerosis
por: Zheng, Sili, et al.
Publicado: (2023)

Serum Metrnl levels are decreased in subjects with overweight or obesity and are independently associated with adverse lipid profile
por: Ding, Xiaoyu, et al.
Publicado: (2022)

Serum Metrnl is associated with the presence and severity of coronary artery disease
por: Liu, Zheng‐Xia, et al.
Publicado: (2018)

Serum Metrnl Level is Correlated with Insulin Resistance, But Not with β-Cell Function in Type 2 Diabetics
por: Wang, Chuan, et al.
Publicado: (2019)

Metrnl: a secreted protein with new emerging functions
por: Zheng, Si-li, et al.
Publicado: (2016)

Serum Levels of Meteorin-Like (Metrnl) Are Increased in Patients with Newly Diagnosed Type 2 Diabetes Mellitus and Are Associated with Insulin Resistance
por: Wang, Kexin, et al.
Publicado: (2019)

Metrnl Alleviates Lipid Accumulation by Modulating Mitochondrial Homeostasis in Diabetic Nephropathy
por: Zhou, Yuxia, et al.
Publicado: (2023)

Meteorin-Like Protein (Metrnl) in Obesity, during Weight Loss and in Adipocyte Differentiation
por: Schmid, Andreas, et al.
Publicado: (2021)

Aggravated ulcerative colitis caused by intestinal Metrnl deficiency is associated with reduced autophagy in epithelial cells
por: Zhang, Sai-long, et al.
Publicado: (2020)

Serum vitamin D levels are decreased in patients without remission of Graves’ disease
por: Yasuda, Tetsuyuki, et al.
Publicado: (2012)

Decreased serum levels of IL-27and IL-35 in patients with Graves disease
por: Saeed, Malek-Hosseini, et al.
Publicado: (2020)

Evidence of a Muscle–Brain Axis by Quantification of the Neurotrophic Myokine METRNL (Meteorin-Like Protein) in Human Cerebrospinal Fluid and Serum
por: Berghoff, Martin, et al.
Publicado: (2021)

Decreased levels of interleukin 27 in the serum of vitiligo patients()()
por: Hosseini, Saeed Malek, et al.
Publicado: (2020)

Expression levels and genetic polymorphisms of interleukin-2 and interleukin-10 as biomarkers of Graves’ disease
por: LIANG, CUIGE, et al.
Publicado: (2015)

Decreased circulating levels of ANGPTL8 in Graves’ disease patients
por: Li, Haoxiang, et al.
Publicado: (2019)

Interleukin 39: a new member of interleukin 12 family
por: LU, ZHIYU, et al.
Publicado: (2020)

Mast Cell Degranulation Decreases Lipopolysaccharide-Induced Aortic Gene Expression and Systemic Levels of Interleukin-6 In Vivo
por: Springer, Jason M., et al.
Publicado: (2019)

Impact of a single bout of high-intensity interval exercise and short-term interval training on interleukin-6, FNDC5, and METRNL mRNA expression in human skeletal muscle
por: Eaton, Malcolm, et al.
Publicado: (2018)

Serum Zinc-α2-Glycoprotein Levels Were Decreased in Patients With Premature Coronary Artery Disease
por: Liu, Meijuan, et al.
Publicado: (2019)

Serum vitamin D levels are decreased and associated with thyroid volume in female patients with newly onset Graves’ disease
por: Yasuda, Tetsuyuki, et al.
Publicado: (2012)

Meteorin-like/Metrnl, a novel secreted protein implicated in inflammation, immunology, and metabolism: A comprehensive review of preclinical and clinical studies
por: Li, Zhuoqi, et al.
Publicado: (2023)

Evaluation of interleukins 37 and 38 and vitamin D status in the serum of women with Graves' disease
por: Ibrahim, Hiba Y., et al.
Publicado: (2022)

Decreased Serum Level of Interleukin-22 Correlates with Hepcidin in Patients with Hidradenitis Suppurativa
por: PONIKOWSKA, Malgorzata, et al.
Publicado: (2021)

The association between serum adenosine deaminase levels and Graves’ disease
por: Lu, Chun-feng, et al.
Publicado: (2021)

METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPARδ-dependent pathways in skeletal muscle of mice
por: Jung, Tae Woo, et al.
Publicado: (2018)

The myokine meteorin‐like (metrnl) improves glucose tolerance in both skeletal muscle cells and mice by targeting AMPKα2
por: Lee, Jung Ok, et al.
Publicado: (2020)

Serum IL‐36 cytokines levels in type 2 diabetes mellitus patients and their association with obesity, insulin resistance, and inflammation
por: Li, Yan, et al.
Publicado: (2020)

Metrnl ameliorates diabetic cardiomyopathy via inactivation of cGAS/STING signaling dependent on LKB1/AMPK/ULK1-mediated autophagy
por: Lu, Qing-Bo, et al.
Publicado: (2022)

Enhancement of soluble CD28 levels in the serum of Graves’ disease
por: Sun, Zhongwen, et al.
Publicado: (2014)

Protective Effects of Interleukin-37 Expression against Acetaminophen-Induced Hepatotoxicity in Mice
por: Xu, Zhiwei, et al.
Publicado: (2022)

Protective effect of interleukin-36 receptor antagonist on liver injury induced by concanavalin A in mice
por: Peng, Xiao, et al.
Publicado: (2020)

Blocking Interleukin-33 Alleviates the Joint Inflammation and Inhibits the Development of Collagen-Induced Arthritis in Mice
por: Li, Yan, et al.
Publicado: (2020)

Down-regulated resistin level in consequence of decreased neutrophil counts in untreated Grave's disease
por: Peng, Ying, et al.
Publicado: (2016)

Production of Polyclonal Antibody against Interleukin-33 and Assessment of Its Distribution in Murine Liver and Lung
por: Liu, Xiaojin, et al.
Publicado: (2009)

Development and internal validation of a risk model for hyperuricemia in diabetic kidney disease patients
por: Huang, Guoqing, et al.
Publicado: (2022)

Increased Human Interleukin-32 Expression Is Related to Disease Activity of Graves' Disease
por: Yao, Qiuming, et al.
Publicado: (2019)

Decreased Serum Levels of Interleukin-4 and Interleukin-21 in New Pemphigus Vulgaris Patients, but Not Chronic Patients With Inactive Disease Compared to Healthy Controls
por: Shahbazian, Pegah, et al.
Publicado: (2021)

Analysis of Serum Interleukin-37 Level and Prognosis in Patients with ACS
por: Liu, Canjun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_54a1fumns08hv8q9ukkdi8048c